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Aim: To estimate the impact of C60 fullerene aqueous solution (C60FAS) on the rate of transplanted malignant tumor growth and metastasis. 
Methods: Lewis lung carcinoma was transplanted into С57Bl/6J male mice. Conventional methods for the evaluation of antitumor and 
antimetastatic effects have been used. Results: The C60FAS at low single therapeutic dose of 5 mg/kg inhibited the growth of transplanted 
malignant tumor (antitumor effect) and metastasis (antimetastatic effect): the maximum therapeutic effect was found to be of 76.5% for 
the tumor growth inhibition; the increase of animal life span by 22% was found; the metastasis inhibition index was estimated as 48%. 
Conclusion: It was found that water-soluble pristine С60 fullerenes efficiently inhibit the transplanted malignant tumor growth and metastasis.
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Current status of anticancer therapy indicates the 
necessity for active search of new agents that will be ef-
fective against primary tumor and metastases but dem-
onstrate the minimal level of side effects. As promising 
antitumor agents could be proposed C60 fullerenes — 
a unique class of carbon allotropes, which exhibits the 
biological activity both in vitro and in vivo [1–3].
The water-soluble pristine (unmodified) C60 fuller-
enes are nontoxic at low physiological concentrations 
[4–7], they can penetrate through the membrane 
of cells [8–10] and have strong antioxidant properties 
[11]. Murugesan et al. [12] have demonstrated the 
substantial antiangiogenic activity of C60 fullerenes 
against either basic fibroblast growth factor- or vascular 
endothelial growth factor-induced angiogenesis in the 
chick chlorioallantoic membrane model. It is known 
that an imbalance in the levels of these factors causes 
many serious diseases including malignant growth [13].
Thus, the purpose of this study was to evaluate the 
impact of water-soluble pristine C60 fullerenes on the 
transplanted tumor growth and metastasis.
The samples of C60 fullerene aqueous solution 
(C60FAS) were prepared as follows [14]. We used a satu-
rated solution of pure C60 fullerenes (purity 99.5%) in tol-
uene and the same amount of distilled water in an open 
beaker. Two phases are formed. Then we applied an ul-
trasonic bath as long as the toluene needs to evaporate 
completely. Meanwhile the water phase became yellow 
colored, indicating that the aqueous fullerene solution 
has been formed. Thereafter we filtered the aqueous 
solution from undissolved C60 fullerenes. As a result 
we prepared the C60FAS sample with maximum concen-
tration of C60 fullerenes in water 1.0 mg/ml. The C60FAS 
sample is stable during 18 months at 4 ˚C.
Theoretical calculations [15–16] showed that C60FAS 
contains both the single C60 molecules and their clus-
ters and solids (with sizes of ~0.7–4 nm in dependence 
of C60 fullerene concentration in water) in the hydrated 
state. Moreover, C60 fullerenes structure the water, 
absorbed by DNA molecules [17], and thus they can 
affect the DNA functioning in the biological systems.
State of C60 fullerenes in water was monitored us-
ing STM technique (NT-MDT, Russia). Samples were 
deposited on Au(111) surface by precipitation from 
aqueous solution droplet.
It is important to note that used C60FAS in our 
experiments does not show a cytotoxic effect with 
respect to both normal and transformed cells at con-
centrations below 1.0 mg/ml [6].
The male mice of С57Bl/6J line (20–21 g of b.w.) 
were kept in a vivarium on a standard diet. The average 
temperature in a vivarium was 201 ˚ C. All experiments 
were performed in accordance with the international 
principles of European Convention for protection 
of vertebrate animals.
Tumor transplantation (Lewis lung carcinoma) 
was performed by intramuscular injection to the 
animal’s limb (initial number of tumor cells ~5·105, 
antitumor effect) or to the pad of animal’s limb (initial 
number of tumor cells ~1·106, antimetastatic effect). 
It is well known that this tumor is characterized 
by a high degree of metastasis into the lung.
The C60FAS in the volume of 0.1 ml (initial concen-
tration of C60 fullerenes in water was 1.0 mg/ml) was 
injected intraperitoneally to the animals with trans-
planted tumor (group 1). Injection of C60FAS was start-
ed in a day after transplantation of tumor, which visually 
appeared on the 10th day. The schedule of C60FAS 
administration was based on the data obtained by [18]. 
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Finally, group 0 (mice with transplanted tumor without 
C60FAS injection) was used as a control. Initial number 
of animals in each group was 5 in Experiment 1 (an-
titumor effect), 7 in Experiment 2 (antitumor effect) 
and 7 in Experiment 3 (antimetastatic effect). On the 
20th day (Experiment 3) all animals were sacrificed and 
autopsied to calculate the number of metastases in the 
lung by conventional method.
It is also important to note that these experiments 
were performed in different time: Experiment 1 — end 
of spring — summer 2010; Experiment 2 — end of win-
ter — spring 2011; Experiment 3 — end of spring — 
summer 2011.
Antitumor effectiveness of the applied technology 
was estimated by following quantitative indicators:
k1TGI = [(V0 – V1)/V0]•100% — tumor growth inhibition 
(TGI, %): , where V0 and V1  are the average values of tumor 
volume in animals of group 0 (control) and experimental 
group 1, respectively; V = (a + b)3/16, where а and b are 
the length and width (in mm) of the tumor site;
k1IAL = [(t1 – t0)/t0]•100% — increasing of animal life 
(IAL, %): , where t0 and t1 are average life span of ani-
mals (in days) in group 0 (control) and experimental 
group 1, respectively;
k1MII = [(A0•B0 – A1•B1)/A0•B0]•100% — metastasis 
inhibition index (MII, %): , where А0 and А1 are frequency 
of metastasis in the group 0 (control) and experimental 
group 1, respectively; В0 and В1 are average number 
of metastases in certain organ of animals in group 
0 (control) and experimental group 1, respectively.
Statistical analysis of results was performed us-
ing STATISTICA software package. On significance 
of differences was analysed using the parametric 
(Student’s t-test) method [19]. The differences were 
considered as valid at p<0.05.
The STM images of submonolayer C60 fullerene film 
deposited from aqueous solution (C60 fullerene con-
centration in water was 1.0 mg/ml) on Au(111) surface 
are shown on Figure. They revealed almost random 
arrangement of C60 fullerene clusters with sizes up to 
~2.8 nm (the first stable sphere-like cluster consist-
ing of 13 hydrated C60 fullerenes [15–16]) (Figure, a). 
Despite of the mobility of C60 molecules on Au(111) 
at room temperature we were able to image single 
C60 molecules (Figure, b).
a b
Figure. a) Large scale STM image of submonolayer C60 fullerene film 
deposited from aqueous solution (C60 fullerene concentration in water 
was 1 mg/ml) on Au(111) surface. Some C60 fullerene clusters are 
aligned along preferential direction <112>; b) Single C60 fullerenes. 
Lateral size is increased because of shape of the tip. Inset: cross-
section along line AB. Scanning parameters: It=40 pA, Ut=0.7 V.
Results of antitumor effect of C60FAS, obtained in Ex-
periment 1 and Experiment 2, are presented in Table 
1 and 2, respectively. 
Table 1. Experiment 1 (antitumor effect): start of tumor transplantation — 
25.05.2010. Start of C60FAS injection after tumor transplantation — 27.05.2010
Days after tumor 
transplantation
Group 
0 (control)
n
Group 1
(injection of C60FAS 
after tumor transplan-
tation)
n
Tumor growth in-
hibition, k1TGI, %*
11 5 5 54.5
14 5 5 71.9
17 5 5 74.0
21 3 5 74.4
23 2 5 76.5
25 2 5 73.1
28 2 5
30 1 5
36 0 5
39 5
43 3
66 1
77 0
Note: n — number of mice; *the differences are statistically significant com-
pared with the control (p < 0.05).
Table 2. Experiment 2 (antitumor effect): start of tumor transplantation — 
17.02.2011. Start of C60FAS injection after tumor transplantation — 19.02.2011. 
The increase of animal life span (k1IAL, %) is given in parentheses
Days after tumor 
transplantation
Group 0 
(control)
N
Group 1 (injection 
of C60FAS after tumor 
transplantation)
n
Tumor growth in-
hibition, k1TGI, %*
13 7 7 4.0
16 7 7 25.1
21 7 7 5.4
23 4 7 17.0
27 2 6 5.0
29 2 6
30 0 6
33 4
34 2
37 0
(k1IAL=21.8%)*
Note: n — number of mice; *the differences are statistically significant com-
pared with the control (p < 0.05).
The inhibition effect of C60 fullerenes on the tumor 
growth was observed on the 11th day (Experiment 1) 
and the 13th day (Experiment 2) of the experiment. The 
maximum value of inhibition of the tumor growth was 
found to be of 76.5% on the 23th day (Experiment 1) and 
of 25.1% on the 16th day (Experiment 2) of the experi-
ment. Last animal in the control group 0 died on the 36th 
day (Experiment 1) and the 30th day (Experiment 2) of the 
experiment. It should be noted that all 5 mice, injected 
by C60 fullerenes (group 1; Experiment 1), lived 39 days. 
Last animal of the experimental group 1 died on the 
77th day (Experiment 1) and the 37th day (Experiment 2) 
of the experiment. The increase of animal life was found 
to be of 21.8% in Experiment 2. Moreover, it was deter-
mined that the average tumor volume in the control group 
exceeded this parameter in the group 1 by ~3 fold on the 
28th day after tumor transplantation in Experiment 2.
The metastasis inhibition index (k1MII) was obtained 
as 48% in the study of antimetastatic effect of C60FAS 
(Experiment 3).
In conclusion, the C60FAS containing hydrated 
single C60 molecules and C60 clusters with size up to 
~2.8 nm without showing direct cytotoxicity at low sin-
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gle therapeutic dose of 5 mg/kg [6] demonstrates the 
inhibition of growth of transplanted tumor (antitumor ef-
fect): the maximum therapeutic effect was determined 
as 76.5% in Experiment 1 and 25.1% in Experiment 2; 
the increase of animal life span by 21.8% was found 
in Experiment 2. The metastasis inhibition index was 
obtained as 48% (antimetastatic effect, Experiment 3). 
Finally, the anticancer affect of C60FAS was confirmed 
by histological data for the animal tumors of control and 
investigated group in Experiment 3 [20]. The obtained 
results can be explained as a result of the high antioxi-
dant activity of C60 fullerenes [11], neutralizing excess 
reactive oxygen species in the cell [20], and possibly 
blocking the specific cell receptors, for example, en-
dothelial growth factor receptors [12]. The proposed 
method of C60FAS application for the inhibition of tumor 
growth is promising for experimental oncology and may 
be tested in the future studies [21].
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